Stocks

“These 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth Capital”

“Cellectar Biosciences (CLRB)… Are other analysts in agreement? They are. 5 Buys and no Holds or Sells have been issued in the last three months. So, the message is clear: CLRB is a Strong Buy. Given the $5.48 average price… Continue Reading…

Stocks

“3 Big Dividend Stocks Yielding Over 8%; Jefferies Says ‘Buy’”

“Compass Diversified Holdings (CODI)… Overall, CODI has a Moderate Buy from the analyst consensus rating, with 2 Buys and 1 Hold given in recent weeks. The stock’s share price is $16.91, and the $21 average price target suggests room for 24.5%… Continue Reading…